Literature DB >> 24326112

[Multidisciplinary guideline irritable bowel syndrome].

Hèlen Woutersen-Koch1, André J P M Smout, Carla E Flik, Carel T J Hulshof, Niek J de Wit, Henriëtte E van der Horst.   

Abstract

The multidisciplinary guideline 'Diagnostics and treatment of irritable bowel syndrome (IBS)' provides the basis for a properly coordinated collaboration between the patient suffering from IBS and all healthcare providers involved in his or her treatment, such as the general practitioner, gastroenterologist, internist, occupational-health physician, dietitian and psychologist. The diagnosis 'IBS' is often made in accordance with diagnostic criteria, such as the Rome III criteria, but a somatic condition needs to be excluded first. If there are no indications for this, additional diagnostic tests are not necessary. Management of the condition consists primarily of advice on life-style plus non-pharmacological interventions, in addition to explaining the condition and providing information. Drug treatment is rarely indicated. If the IBS symptoms have a significant impact on quality of life and patients do not respond to the measures taken in accordance with this general policy, there are three options for psychotherapeutic treatment. When the symptoms result in absenteeism or other work-related problems, the doctor can advise the patient to contact the occupational-health physician and to search for specific solutions in consultation with the employer. When individual advice is required or if the patient's diet is not well-balanced, a referral to the dietitian will follow.

Entities:  

Mesh:

Year:  2013        PMID: 24326112

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  3 in total

1.  Targeted screening for Coeliac Disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information.

Authors:  Leyla Mohseninejad; Talitha Feenstra; Henriëtte E van der Horst; Hèlen Woutersen-Koch; Erik Buskens
Journal:  Eur J Health Econ       Date:  2012-11-18

Review 2.  Pharmacological treatments for patients with irritable bowel syndrome: An umbrella review of systematic reviews and meta-analyses.

Authors:  Di Qin; Ling Yue; Bin Xue; Min Chen; Tai-Chun Tang; Hui Zheng
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

3.  Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial.

Authors:  Daniël R Hoekman; Arine M Vlieger; Pieter C Stokkers; Nofel Mahhmod; Svend Rietdijk; Nanne K de Boer; Tim G de Meij; Carla Frankenhuis; Geert R D'Haens; Marc A Benninga
Journal:  J Crohns Colitis       Date:  2021-07-05       Impact factor: 9.071

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.